Calculator topics: Difference between revisions
Jump to navigation
Jump to search
(11 intermediate revisions by 2 users not shown) | |||
Line 16: | Line 16: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + |ACTION ICU | | align="left" style="background:#F5F5F5;" + |[[ACTION ICU risk score]] | ||
| align="left" style="background:#F5F5F5;" + |Predicts | | align="left" style="background:#F5F5F5;" + |Predicts need for ICU care in stable adults with [[Unstable angina / non ST elevation myocardial infarction|NSTEMI]] | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
Line 31: | Line 31: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Anticoagulation | ! align="center" style="background:#DCDCDC;" + |Anticoagulation | ||
| align="left" style="background:#F5F5F5;" + |ATRIA | | align="left" style="background:#F5F5F5;" + |ATRIA bleeding risk score | ||
| align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin | | align="left" style="background:#F5F5F5;" + |Determines bleeding risk for patients on warfarin | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Arrythmia | ! align="center" style="background:#DCDCDC;" + |Arrythmia | ||
| align="left" style="background:#F5F5F5;" + |ATRIA | | align="left" style="background:#F5F5F5;" + |ATRIA stroke risk score | ||
| align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation | | align="left" style="background:#F5F5F5;" + |Determines stroke risk in patients with atrial fibrillation | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + |Atrial | | align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke (Framingham Heart Study) | ||
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation | | align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke in patients with atrial fibrillation | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ! align="center" style="background:#DCDCDC;" + |Arrythmia/Stroke | ||
| align="left" style="background:#F5F5F5;" + |Atrial | | align="left" style="background:#F5F5F5;" + |Atrial fibrillation 5-year risk of stroke or death (Framingham Heart Study) | ||
| align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation | | align="left" style="background:#F5F5F5;" + |Predicts 5-year risk of stroke or death in patients with atrial fibrillation | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Alcoholism | ! align="center" style="background:#DCDCDC;" + |Alcoholism | ||
| align="left" style="background:#F5F5F5;" + |CAGE | | align="left" style="background:#F5F5F5;" + |CAGE questions | ||
| align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism | | align="left" style="background:#F5F5F5;" + |Screens for excessive drinking and alcoholism | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Syncope | ! align="center" style="background:#DCDCDC;" + |Syncope | ||
| align="left" style="background:#F5F5F5;" + |Canadian | | align="left" style="background:#F5F5F5;" + |Canadian syncope risk score | ||
| align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope | | align="left" style="background:#F5F5F5;" + |Predicts 30-day serious adverse events in patients presenting with syncope | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
Line 116: | Line 116: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |VTE | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + |DASH | | align="left" style="background:#F5F5F5;" + |[[DASH prediction score]] | ||
| align="left" style="background:#F5F5F5;" + |Predicts | | align="left" style="background:#F5F5F5;" + |Predicts disease recurrence in patients with prior unprovoked [[Venous thromboembolism|VTE]] | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + |DAPT | | align="left" style="background:#F5F5F5;" + |[[DAPT score]] | ||
| align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged | | align="left" style="background:#F5F5F5;" + |Predicts which patients will benefit from prolonged [[dual antiplatelet therapy]] after coronary stent placement | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
Line 196: | Line 196: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Bleeding | ! align="center" style="background:#DCDCDC;" + |Bleeding | ||
| align="left" style="background:#F5F5F5;" + |IMPROVE bleeding risk score | | align="left" style="background:#F5F5F5;" + |[[IMPROVE bleeding risk score]] | ||
| align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission | | align="left" style="background:#F5F5F5;" + |Estimates the probability of major or clinically important in-hospital bleeding from the time of hospital admission up to 14 days following admission | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |VTE | ! align="center" style="background:#DCDCDC;" + |VTE | ||
| align="left" style="background:#F5F5F5;" + |[[ | | align="left" style="background:#F5F5F5;" + |[[IMPROVE VTE risk score]] | ||
| align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge | | align="left" style="background:#F5F5F5;" + |Estimates the probability of clinically evident acute venous thromboembolism from the time of hospital admission to discharge | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
Line 271: | Line 271: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |DVT | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + |[[ | | align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (original)]] | ||
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |DVT | ! align="center" style="background:#DCDCDC;" + |DVT | ||
| align="left" style="background:#F5F5F5;" + |[[Wells score | | align="left" style="background:#F5F5F5;" + |[[Wells score for DVT (modified)]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of DVT | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |PE | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + |[[ | | align="left" style="background:#F5F5F5;" + |[[Wells score for PE (original)]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |PE | ! align="center" style="background:#DCDCDC;" + |PE | ||
| align="left" style="background:#F5F5F5;" + |[[ | | align="left" style="background:#F5F5F5;" + |[[Wells score for PE (modified)]] | ||
| align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE | | align="left" style="background:#F5F5F5;" + |Estimates the pre-test probability of PE | ||
| align="center" style="background:#F5F5F5;" + |Score | | align="center" style="background:#F5F5F5;" + |Score | ||
Line 441: | Line 441: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ! align="center" style="background:#DCDCDC;" + |Coronary artery disease | ||
| align="left" style="background:#F5F5F5;" + |Sgarbossa's | | align="left" style="background:#F5F5F5;" + |[[Sgarbossa's criteria]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + |Assists to diagnose acute [[ST elevation myocardial infarction|MI]] in patients with [[Left bundle branch block|LBBB]] | ||
| align="center" style="background:#F5F5F5;" + |Criteria | | align="center" style="background:#F5F5F5;" + |Criteria | ||
|- | |- |
Latest revision as of 06:02, 10 February 2019
Calculator project |
---|
Introduction |
Guide |
Template |
Topics |
Validated Scores |
Alphabetic Order |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]